Action Global Communications helps Boehringer Ingelheim launch new asthma treatment in the CEE

Action Global Communications recently supported our client, Boehringer Ingelheim in launching a new treatment option for asthma sufferers in Central and Eastern Europe. An Expert Forum was held in Vienna to officially launch tiotropium Respimat® in the CEE region, and was attended by over 200 doctors and members of the media. Speaking at the event were several medical experts, who highlighted the need for such developments in the asthma treatment landscape.

Action Global Communications arranged for media from across the CEE region to attend the Expert Forum and hear about the latest developments in asthma treatment. The speaker presentations were followed by a media workshop where a lively Q&A session was held between the journalists and expert speakers, answering questions about what this development means for asthma sufferers in the region, and the wider medical community.